# NSAID Drug Interaction Study

> **NCT01884272** · PHASE1 · COMPLETED · sponsor: **Ardea Biosciences, Inc.** · enrollment: 24 (actual)

## Conditions studied

- Gout

## Interventions

- **DRUG:** lesinurad 400 mg
- **DRUG:** naproxen 250 mg
- **DRUG:** indomethacin 25 mg

## Key facts

- **NCT ID:** NCT01884272
- **Lead sponsor:** Ardea Biosciences, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-06
- **Primary completion:** 2013-08
- **Final completion:** 2013-10
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2013-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01884272

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01884272, "NSAID Drug Interaction Study". Retrieved via AI Analytics 2026-07-16 from https://api.ai-analytics.org/clinical/NCT01884272. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
